Aignosis
Latest round
- Seed
Last raised
- Oct 2026
Total raised
- $0.4M
Investors
- 2
About Aignosis
Based in Jaipur, India, and founded in 2024, Aignosis develops AI-driven solutions for the early screening and detection of autism in children using computer vision and machine learning, enabling non-invasive and affordable screening through standard webcams. The company was co-founded by Raksheet Jain and Divyansh Mangal. The company offers an AI-based autism screening platform that analyzes behavioral biomarkers such as eye movement, attention patterns, and facial responses from short video interactions. The solution delivers screening results within minutes and is intended to support clinicians and caregivers in identifying children who may require further clinical evaluation. Aignosis generates revenue through paid autism screening services offered to clinics, institutions, and caregivers. Its model is centered on providing low-cost, scalable access to early screening tools within the healthcare ecosystem.
Who invested in Aignosis
2 investors across 1 round
See all investors in Aignosis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 1, 2026
Amount
$0.4M
Investors
Questions about Aignosis
Who invested in Aignosis?
Aignosis has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aignosis raised?
Aignosis has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aignosis last raise money?
Aignosis's most recent round on record is a Seed, in Oct 2026.
What does Aignosis do?
Based in Jaipur, India, and founded in 2024, Aignosis develops AI-driven solutions for the early screening and detection of autism in children using computer vision and machine learning, enabling non-invasive and affordable screening through standard webcams.
Where is Aignosis headquartered?
Aignosis is headquartered in Jaipur, India.
Which VCs invest in companies like Aignosis?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, MPCi, Zijin Venture Capital and Legend Capital back healthcare companies at Aignosis's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Aignosis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.